secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0000950170-25-040784
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health announces 1-for-25 reverse stock split effective March 24 to meet Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split at 1-for-25 ratio, effective March 24, 2025 at 12:01 am ET.
- Purpose: support compliance with Nasdaq listing standards and attract institutional investors.
- No fractional shares; stockholders otherwise entitled to fractional shares receive cash in lieu.
- New CUSIP number for post-split common stock is 47010C888.
- Stockholder approval obtained at March 13, 2025 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025040784/0000950170-25-040784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025040784/jagx-20250318.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-040784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer